肝細胞索 的英文怎麼說

中文拼音 [gānxìbāosuǒ]
肝細胞索 英文
hepatic cell cords
  • 肝 : 名詞（人和高等動物的消化器官之一） liver
  • 細 : 形容詞1 （條狀物橫剖面小） thin; slender 2 （顆粒小） in small particles; fine 3 （音量小） thin ...
  • 胞 : Ⅰ名詞1 （胞衣） afterbirth2 （同一個國家或民族的人） fellow countryman; compatriot Ⅱ形容詞（同胞...
  • 索 : Ⅰ名詞1 （大繩子; 大鏈子） a large rope 2 （姓氏） a surname Ⅱ動詞1 （搜尋; 尋找） search 2 （要; ...
  • 細胞 : cell; sytes; bioplast; cella; [口語] gene; [生物學] cellule; cellule cellulli cellulo ; cello ; k...
  1. The variety of the activity of na + / k + - atpase, ca2 + - atpase and sod by increase calcium concentration in the water, and the effects of cd2 +, estradiol - 17 and ca2 + on the lymphocyte proliferation from blood and head kidney of ctenopharyngodon idellus were also investigated the significance of this paper is that to research the toxicity of cadmium to the fish and to search the mechanism of the cadmium toxicity to the fish. and the protection of calcium on cd2 + toxicity

    本論文研究了鎘對草魚的毒性作用，比較了在不同鈣濃度條件下，其鰓、肝臟、腦等組織中sod 、 na ~ + k ~ + ? atp酶、 ca ~ （ 2 + ） ? atp酶的活性變化規律以及鎘和17 ?雌二醇對草魚血液及頭腎淋巴細胞增殖的影響，評價鎘對魚類的毒害作用，探索鎘的毒害機理。
  2. The hepatic adenoma is on the right and is composed of cells that closely resemble normal hepatocytes, but the neoplastic liver tissue is disorganized hepatocyte cords and does not contain a normal lobular architecture

    右側為肝臟腺瘤，腫瘤細胞類似於正常肝細胞，但腫瘤組織中肝細胞條索排列紊亂，無正常肝小葉結構。
  3. Note that this hepatocellular carcinoma is composed of liver cords that are much wider than the normal liver plate that is two cells thick

    注意此肝細胞癌由寬于正常肝板（厚度為2個細胞）的肝細胞條索組成。
  4. Pathologically, the tumor is characterized by abundant fibrous stroma in which cords and / or tubular structures of tumor cells are embedded

    病理上，硬化型肝癌可見到索狀或管狀腫瘤細胞夾雜在豐富的纖維組織中。
  5. According to the characteristics of the stepping motor, the open - loop control solution was adopted

    而對于培養動物肝細胞的生物反應器的研究，還處于探索階段。
  6. " presently available systemic therapies for hepatocellular carcinoma have no documented survival benefit, " he said. " our study establishes sorafenib as the new reference standard for systemic therapy in these patients.

    他說： 「現在所應用的肝細胞癌全身治療對于生存率沒有任何效果，我們的研究為這類病人建立了以索拉非尼為新參考標準的全身治療方案。 」
分享友人
分享到 Line

分享到臉書